chr10-112163799-T-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001244949.2(GPAM):āc.1325A>Gā(p.Asp442Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000244 in 1,575,318 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001244949.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GPAM | NM_001244949.2 | c.1325A>G | p.Asp442Gly | missense_variant | 14/22 | ENST00000348367.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GPAM | ENST00000348367.9 | c.1325A>G | p.Asp442Gly | missense_variant | 14/22 | 1 | NM_001244949.2 | P1 | |
GPAM | ENST00000369425.5 | c.1325A>G | p.Asp442Gly | missense_variant | 14/19 | 1 |
Frequencies
GnomAD3 genomes AF: 0.000315 AC: 48AN: 152220Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000426 AC: 107AN: 251222Hom.: 0 AF XY: 0.000412 AC XY: 56AN XY: 135776
GnomAD4 exome AF: 0.000237 AC: 337AN: 1423098Hom.: 2 Cov.: 25 AF XY: 0.000256 AC XY: 182AN XY: 710494
GnomAD4 genome AF: 0.000315 AC: 48AN: 152220Hom.: 0 Cov.: 33 AF XY: 0.000403 AC XY: 30AN XY: 74382
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2021 | The c.1325A>G (p.D442G) alteration is located in exon 1 (coding exon 1) of the GPAM gene. This alteration results from a A to G substitution at nucleotide position 1325, causing the aspartic acid (D) at amino acid position 442 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at